Nitrated fatty acids suppress angiotensin II-mediated fibrotic remodelling and atrial fibrillation.

AIM Atrial fibrosis, one of the most striking features in the pathology of atrial fibrillation (AF), is promoted by local and systemic inflammation. Electrophilic fatty acid nitroalkenes, endogenously generated by both metabolic and inflammatory reactions, are anti-inflammatory mediators that in synthetic form may be useful as drug candidates. Herein we investigate whether an exemplary nitro-fatty acid can limit atrial fibrosis and AF. METHODS AND RESULTS Wild-type C57BL6/J mice were treated for 2 weeks with angiotensin II (AngII) and vehicle or nitro-oleic acid (10-nitro-octadec-9-enoic acid, OA-NO2, 6 mg/kg body weight) via subcutaneous osmotic minipumps. OA-NO2 significantly inhibited atrial fibrosis and depressed vulnerability for AF during right atrial electrophysiological stimulation to levels observed for AngII-naive animals. Left atrial epicardial mapping studies demonstrated preservation of conduction homogeneity by OA-NO2. The protection from fibrotic remodelling was mediated by suppression of Smad2-dependent myofibroblast transdifferentiation and inhibition of Nox2-dependent atrial superoxide formation. CONCLUSION OA-NO2 potently inhibits atrial fibrosis and subsequent AF. Nitro-fatty acids and possibly other lipid electrophiles thus emerge as potential therapeutic agents for AF, either by increasing endogenous levels through dietary modulation or by administration as synthetic drugs.

[1]  Simon C Watkins,et al.  Conjugated Linoleic Acid Is a Preferential Substrate for Fatty Acid Nitration* , 2012, The Journal of Biological Chemistry.

[2]  Megan L. McCain,et al.  Connexin43 ablation in foetal atrial myocytes decreases electrical coupling, partner connexins, and sodium current. , 2012, Cardiovascular research.

[3]  A. Lojek,et al.  New Role for L-Arginine in Regulation of Inducible Nitric-Oxide-Synthase-Derived Superoxide Anion Production in Raw 264.7 Macrophages , 2011, TheScientificWorldJournal.

[4]  J. D. de Bakker,et al.  Fibrosis and Cardiac Arrhythmias , 2011, Journal of cardiovascular pharmacology.

[5]  Douglas L. Jones,et al.  Atrial tachycardia/fibrillation in the connexin 43 G60S mutant (Oculodentodigital dysplasia) mouse. , 2011, American journal of physiology. Heart and circulatory physiology.

[6]  L. Lai,et al.  Tachycardia of atrial myocytes induces collagen expression in atrial fibroblasts through transforming growth factor β1. , 2011, Cardiovascular research.

[7]  D. Katritsis,et al.  Inhibition of the Renin‐Angiotensin System for Prevention of Atrial Fibrillation , 2010, Pacing and clinical electrophysiology : PACE.

[8]  Jeroen J. Bax,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  A. Camm,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.

[10]  Alan Garfinkel,et al.  So little source, so much sink: requirements for afterdepolarizations to propagate in tissue. , 2010, Biophysical journal.

[11]  Y. E. Chen,et al.  Nitro-Oleic Acid Inhibits Angiotensin II–Induced Hypertension , 2010, Circulation research.

[12]  S. Hazen,et al.  Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation , 2010, Nature Medicine.

[13]  Markus Grube,et al.  Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. , 2010, Journal of the American College of Cardiology.

[14]  Y. Iwasaki,et al.  Recruitment of immune cells across atrial endocardium in human atrial fibrillation. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[15]  S. Ylä-Herttuala,et al.  Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells , 2009, The Journal of Biological Chemistry.

[16]  M. P. Cole,et al.  Nitro-fatty Acid Metabolome: Saturation, Desaturation, β-Oxidation, and Protein Adduction* , 2009, Journal of Biological Chemistry.

[17]  S. Nattel,et al.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[18]  Mark A Sussman,et al.  Role of Rac1 GTPase activation in atrial fibrillation. , 2007, Journal of the American College of Cardiology.

[19]  M. Capecchi,et al.  Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. , 2004, The American journal of pathology.

[20]  G Hindricks,et al.  Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease , 2004, Heart.

[21]  F. Esmailian,et al.  Atrial Extracellular Matrix Remodeling and the Maintenance of Atrial Fibrillation , 2004, Circulation.

[22]  G. Hindricks,et al.  Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. , 2003, Journal of the American College of Cardiology.

[23]  K. Channon,et al.  A Myocardial Nox2 Containing NAD(P)H Oxidase Contributes to Oxidative Stress in Human Atrial Fibrillation , 2003, Circulation research.

[24]  I. Fridovich,et al.  Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. , 2001, Circulation research.

[25]  D. V. Van Wagoner,et al.  Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation , 2001, Circulation.

[26]  D. Sorescu,et al.  Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[27]  O. Inanami,et al.  Roles of p38 MAPK, PKC and PI3‐K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes , 2000, FEBS letters.

[28]  B. Davidson,et al.  Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. , 1998, Circulation research.

[29]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[30]  Myron S. Cohen,et al.  Free radicals and phagocytic cells , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  S. Barnes,et al.  Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. , 1994, The Journal of biological chemistry.

[32]  J. Ross,et al.  ACC/AHA guidelines for cardiac catheterization and cardiac catheterization laboratories. American College of Cardiology/American Heart Association Ad Hoc Task Force on Cardiac Catheterization. , 1991, Journal of the American College of Cardiology.

[33]  Ivan C. Gerling,et al.  Myofibroblast-mediated mechanisms of pathological remodelling of the heart , 2013, Nature Reviews Cardiology.